CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-08). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2467 · Search date 2026-08-08 · Methodology v0.7

Menstrual cup use,
does it really help with Associated with increased copper intrauterine-device expulsion?

30-Second Summary
C
Evidence Grade C · 54 · Safety warning
The association was large for the smaller copper IUD but was not shared by every device type
Expulsion can cause contraceptive failure and require reinsertion. Seek prompt device-position assessment for changed strings, a palpable device, unusual bleeding, or pain.
What the
research shows
The grade is C. In a secondary observational analysis of 1,046 participants in a three-year copper-IUD trial, expulsion occurred in 58/250 cup users (23.2%) and 75/796 nonusers (9.4%): an absolute difference of 13.8 points and crude OR 2.90 (95% CI 1.99-4.24). Cup use itself was not randomized, and the adjusted increase was confirmed only with NTCu380-Mini.
What the
ads claim
Menstrual cups are sold in Korea and copper IUDs are clinician-inserted. Counseling should discuss breaking the seal and avoiding traction on strings, but the same risk multiplier cannot be assigned to every copper-IUD design.
*

Useful facts when choosing a product

  • The parent trial compared TCu380A with the smaller Nova-T-frame NTCu380-Mini.
  • The overall 36-month absolute difference was 13.8 percentage points, but device-specific results differed.
  • Accidental self-removal was 3/53 vs 0/150 with TCu380A and 20/197 vs 7/646 with NTCu380-Mini.
Gap Measurement · Verdict 2467 · C 54
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Brown et al. analyzed NCT03124160 secondarily. Of 1,105 randomized in the parent IUD trial, 1,046 with successful placement, follow-up, and menstrual-product data were analyzed. Expulsion included spontaneous partial or complete expulsion and accidental self-removal; IUD presence was checked at scheduled visits by digital, speculum, or sonographic examination. Exposure meant any reported cup use, with disc-only users included in the primary exposure definition. After the signal appeared, investigators added menstrual-product tracking and advised against cup use, leaving 19.3% of early visits without product-use documentation. The registered randomized comparison concerned IUD type, not cup use. Original funding was from the Bill & Melinda Gates Foundation, NICHD, and Mona Lisa N.V.

02

Why this is classified as C (54)

A hard-event signal and large absolute difference support the harm claim, but this was one nonrandomized secondary exposure analysis with protocol-dependent measurement, residual confounding, and no frequency or timing analysis, giving C with 54 points.

Counterpoint. The grade reflects evidence strength, not moderate severity. Overall expulsion was not increased for TCu380A itself.

Rejudgment record. Cross-check applied — Absolute and device-specific odds from a nonrandomized cup-exposure analysis nested within an IUD trial, with confounding and mid-study measurement changes

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Increased expulsion with NTCu380-Mini and cup useCRates were 25.4% vs 8.5%, adjusted OR 3.13.
Increased overall expulsion with TCu380A and cup useDRates were 15.1% vs 13.3%, OR 1.16, not confirming an increase.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Nonrandomized secondary observational analysis within a copper-IUD randomized trial796Bill & Melinda Gates Foundation, NICHD, and Mona Lisa N.V.Partial or complete expulsion and accidental self-removal through 12 and 36 monthsAt 36 months, 23.2% vs 9.4%, absolute difference 13.8 points, crude OR 2.90 (1.99-4.24); NTCu380-Mini adjusted OR 3.13 (1.16-8.46)Pivotal single observational analysis
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-08).

Brown JE, Creinin MD, Wu H, et al. Menstrual cup use and intrauterine device expulsion in a copper intrauterine device randomized trial. Contraception. 2024;134:110415. PMID: 38431257. PMCID: PMC11081833. DOI: 10.1016/j.contraception.2024.110415.
checked
ClinicalTrials.gov. NCT03124160. Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-08 · Corrections: none

Cite this verdict

Menstrual cup use x associated with increased copper-IUD expulsion Evidence Grade C card
[Chamgap] Menstrual cup use x associated with increased copper-IUD expulsion — Evidence Grade C·54. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/womens/menstrual-cup-copper-iud-expulsion/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.